Skip to content

Fosun Said to Mull Sale of India’s $3.8 Billion Gland Pharma

  • Chinese group works with adviser to informally gauge interest
  • Potential sale has attracted industry players, buyout firms
Updated on

Billionaire Guo Guangchang’s Shanghai Fosun Pharmaceutical Group Co. is considering a sale of Indian drugmaker Gland Pharma Ltd. after receiving interest from potential buyers, people familiar with the matter said. 

Fosun Pharma, a listed arm of Chinese conglomerate Fosun International Ltd., has been working with an adviser as it informally gauges interest in its controlling stake in Gland, the people said. Companies in the industry and buyout firms are in the early stages of studying the business, the people said, asking not to be identified because the matter is private.